PMV Pharmaceuticals (NASDAQ:PMVP) reported quarterly losses of $(0.38) per share. This is a 31.03 percent decrease over losses of $(0.29) per share from the same period last year.
Bitcoin, Ethereum, Dogecoin Tumble Amid Hawkish FOMC Minutes Reveal: Analyst Says King Crypto Prime For Explosive Surge As History Set To Repeat Itself
Major cryptocurrencies traded in the red on Wednesday evening as the Federal Open Market Committee (FOMC) meeting on June 14 unveiled a solid consensus among board members in favor of further interest rate hikes in 2
